What is the 13F Pro Quality Score for GNLX?

13F Pro ranks GENELUX Corp (GNLX) on the 13F Pro Quality Score, a 0–100 composite of 32 fundamental signals including return on invested capital, free cash flow consistency, balance-sheet strength, earnings quality, growth durability, and valuation discipline. The score refreshes after each 10-K and 10-Q filing on SEC EDGAR. View GNLX's current score at https://13fpro.ai/company/GNLX (free sign-up required for the full ranking).

Where does 13F Pro source GNLX data?

All GENELUX Corp fundamentals and ownership data come directly from SEC EDGAR. GENELUX Corp files with the SEC under CIK 1231457. 13F Pro ingests XBRL financial facts from 10-K and 10-Q filings, Form 13F-HR institutional holdings, and Form 4 insider transactions, with no third-party rewrites or estimates.

What sector is GNLX in?

GENELUX Corp (GNLX) is classified in the Healthcare sector. 13F Pro publishes sector-level fund flow analysis and quality leaders at https://13fpro.ai/research/sector/healthcare.

How often is GNLX research updated on 13F Pro?

GNLX's fundamentals refresh within hours of each new 10-K or 10-Q filing on SEC EDGAR. Institutional ownership updates after each quarterly 13F filing window. Insider transactions update after each Form 4 filing. The 13F Pro Quality Score recalculates after every fundamentals refresh.

GENELUX Corp(GNLX)Stock Analysis

AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →

Healthcare →Nasdaqsmall

Institutional-grade research for retail investors

SEC EDGAR: CIK 1231457 GNLX stock profile & AI dashboard →

13F Pro Quality Score

12.3/100

Rank #2,888 of 2,961 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Email me the moment this company reports earnings

AI Research Report

Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.

Upgrade to Pro

Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

Why GNLX Scores 12/100

exact factor attribution · 2026-09-10

GNLX's composite is held back by free cash flow and profitability. Bars show each factor's exact push vs. a median company, using the same weights the ranking engine applies.

Institutional flow

-0.5 pts

41th pct

Earnings quality

-1.4 pts

36th pct

Earnings growth

-2.2 pts

5th pct

Shareholder dilution

-2.5 pts

0th pct

Revenue growth

-4.0 pts

30th pct

Capital efficiency

-4.7 pts

3th pct

Scale

-7.5 pts

0th pct

Profitability

-7.5 pts

0th pct

Free cash flow

-7.5 pts

0th pct

Factor percentiles are cross-sectional ranks across the ~2,800-stock scored universe, computed from SEC EDGAR filings. Not investment advice.

GNLX Stock Analysis & AI Quality Score

Data updated 2026-09-10

AI stock analysis and institutional research for GENELUX Corp (GNLX), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores GNLX at 12.3/100 on a 32-signal composite quality model, placing it at rank #2,888 of 2,961 stocks — the bottom half of the AI-ranked universe. Based on the latest XBRL financial filings (Q2 2026), GENELUX Corp reports net income of $-9.5M, free cash flow of $-8.0M. Top institutional holders of GNLX by reported 13-F value include WOODWARD DIVERSIFIED CAPITAL, VANGUARD CAPITAL MANAGEMENT, Bleichroeder, based on the most recent SEC filings. GNLX trades on the Nasdaq exchange and files with the SEC under CIK 1231457. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate GNLX daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for GENELUX Corp directly from SEC EDGAR. GENELUX Corp's 13F Pro composite quality score has ranged between 3 and 13 since 2026, currently 12.3 — an improving long-term trajectory across 8 quarterly and live scoring snapshots.

Net Income

Q2 2026

$-9.5M

Free Cash Flow

Q2 2026

$-8.0M

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+0.0% YoY

$8.0KFY 2025

FY22 $11.1MFY23 $170.0KFY24 $8.0KFY25 $8.0K

Net Income

-7.6% YoY

$-32.1MFY 2025

FY22 $-5.2MFY23 $-28.3MFY24 $-29.9MFY25 $-32.1M

Operating Income

-4.8% YoY

$-33.2MFY 2025

FY22 $-3.0MFY23 $-24.2MFY24 $-31.7MFY25 $-33.2M

EPS (Diluted)

+9.5% YoY

$-0.86FY 2025

FY22 $-0.57FY23 $-1.16FY24 $-0.95FY25 $-0.86

Total Assets

-45.2% YoY

$19.0MFY 2025

FY22 $5.5MFY23 $27.9MFY24 $34.7MFY25 $19.0M

Total Debt

—FY 2025

FY22 —FY23 $900.0KFY24 —FY25 —

Op. Cash Flow

-19.0% YoY

$-25.3MFY 2025

FY22 $-3.6MFY23 $-20.3MFY24 $-21.2MFY25 $-25.3M

Free Cash Flow

-22.0% YoY

$-26.4MFY 2025

FY22 $-3.6MFY23 $-21.3MFY24 $-21.6MFY25 $-26.4M

Metric	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Revenue	$8.0K +0.0%	$8.0K -95.3%	$170.0K -98.5%	$11.1M	—
Net Income	$-32.1M -7.6%	$-29.9M -5.6%	$-28.3M -443.4%	$-5.2M	—
Operating Income	$-33.2M -4.8%	$-31.7M -31.2%	$-24.2M -702.0%	$-3.0M	—
EPS (Diluted)	$-0.86 +9.5%	$-0.95 +18.1%	$-1.16 -103.5%	$-0.57	—
Total Assets	$19.0M -45.2%	$34.7M +24.5%	$27.9M +404.3%	$5.5M	—
Total Debt	—	—	$900.0K	—	—
Operating Cash Flow	$-25.3M -19.0%	$-21.2M -4.7%	$-20.3M -467.8%	$-3.6M	—
Free Cash Flow	$-26.4M -22.0%	$-21.6M -1.5%	$-21.3M -488.4%	$-3.6M	—

Get alerted when GNLX's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for GENELUX Corp including:

SEC EDGAR filings (10-K, 10-Q, 8-K)

XBRL financial facts (revenue, EPS, margins)

Insider transactions (Form 4)

Institutional 13F holdings

Quality rankings (32 signals)

AI analyst debates & daily meetings

Historical financial trends

Peer comparison & sector analysis

Top Institutional Holders of GNLX

WOODWARD DIVERSIFIED CAPITAL, LLC
$6.8M2,262,108 sh
VANGUARD CAPITAL MANAGEMENT LLC
$5.0M1,677,724 sh
Bleichroeder LP
$4.2M1,380,666 sh
BlackRock, Inc.
$1.3M439,602 sh
GEODE CAPITAL MANAGEMENT, LLC
$1.3M439,213 sh
CM Management, LLC
$1.2M400,000 sh
BANK OF AMERICA CORP /DE/
$989.7K328,803 sh
VANGUARD FIDUCIARY TRUST CO
$711.4K236,344 sh
FLPUTNAM INVESTMENT MANAGEMENT CO
$696.5K231,405 sh
Global Retirement Partners, LLC
$685.8K227,854 sh

Fund	Value	Shares
WOODWARD DIVERSIFIED CAPITAL, LLC	$6.8M	2,262,108
VANGUARD CAPITAL MANAGEMENT LLC	$5.0M	1,677,724
Bleichroeder LP	$4.2M	1,380,666
BlackRock, Inc.	$1.3M	439,602
GEODE CAPITAL MANAGEMENT, LLC	$1.3M	439,213
CM Management, LLC	$1.2M	400,000
BANK OF AMERICA CORP /DE/	$989.7K	328,803
VANGUARD FIDUCIARY TRUST CO	$711.4K	236,344
FLPUTNAM INVESTMENT MANAGEMENT CO	$696.5K	231,405
Global Retirement Partners, LLC	$685.8K	227,854

More Healthcare Companies

View all Healthcare →

AAPG

ASCENTAGE PHARMA GROUP INTERNATIONAL

AARD

Aardvark Therapeutics, Inc.

ABBV

AbbVie Inc.

ABCL

AbCellera Biologics Inc.

ABEO

ABEONA THERAPEUTICS INC.

ABOS

Acumen Pharmaceuticals, Inc.

ABPWW

Abpro Holdings, Inc.

ABSI

Absci Corp

Put GNLX on your watchlist

Track score changes the day GENELUX Corp files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Popular Research

AAPL

Apple

MSFT

Microsoft

NVDA

NVIDIA

GOOG

Alphabet

AMZN

Amazon

Is GNLX a good stock to buy?

13F Pro's AI-powered analysis of GENELUX Corp (GNLX) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for GNLX are available on the GNLX stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. GNLX is classified as a small company.

Which hedge funds own GNLX?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling GNLX. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of GENELUX Corp's investment landscape.